Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation ( <scp>DapaTAVI</scp> ) randomized trial

Abstract

DapaTAVI will determine the efficacy and safety of dapagliflozin in a broad spectrum of frail patients after AS relief by TAVI.